Overview
Q‑stroke, also called a posterior circulation infarct (PCI), is an ischemic stroke that occurs in the arteries supplying the back (posterior) part of the brain. These vessels include the vertebral arteries, basilar artery, posterior cerebral arteries, and their branches that nourish the brainstem, cerebellum, thalamus, occipital lobes, and the upper spinal cord.
Because the posterior brainstem controls vital functions such as breathing, heart rate, consciousness, and eye movements, a PCI can present with a distinct set of symptoms compared with the more common anterior‑cerebral‑artery strokes.
Who it affects
- Adults >55 years account for ~70 % of cases, but younger patients can be affected, especially those with certain cardiac or vascular disorders.
- Men have a slightly higher incidence (≈55 % male) than women, likely reflecting higher rates of hypertension and smoking in men.
- People with atrial fibrillation, carotid or vertebral artery disease, and those with a history of transient ischemic attacks (TIA) are at increased risk.
Prevalence
Posterior circulation strokes represent about 20‑25 % of all ischemic strokes worldwide (≈150,000–200,000 cases per year in the United States alone) [1][2]. Because the symptoms are often subtle, PCI may be under‑diagnosed, especially in emergency departments lacking high‑resolution vascular imaging.
Symptoms
Symptoms reflect the specific structures affected. The classic “Q” mnemonic (for “Questionable”) helps clinicians recall the most common features, but patients may experience any combination.
Brainstem‑related signs
- Dizziness or vertigo – a sensation of spinning that is often sudden and severe.
- Ataxia – unsteady gait, difficulty walking straight, or a tendency to fall toward one side.
- Nystagmus – involuntary, rapid eye movements that may be horizontal, vertical, or rotatory.
- Diplopia (double vision) – caused by impaired cranial nerve VI (abducens) or III (oculomotor) function.
- Bulbar dysfunction – trouble swallowing (dysphagia), slurred speech (dysarthria), or reduced gag reflex.
- Conjugate gaze palsy – inability to move both eyes together, leading to "eyes‑in‑the‑sunset" appearance.
Cerebellar signs
- Intention tremor – shaking that worsens with purposeful movement.
- Impaired coordination of hands and arms (dysmetria).
- Difficulty with rapid alternating movements (dysdiadochokinesia).
Thalamic / Occipital signs
- Visual field deficits – homonymous hemianopia (loss of half the visual field in both eyes) or quadrantanopia.
- Sensory loss – numbness or tingling affecting the contralateral side of the body.
- Memory or attention disturbances – especially with thalamic involvement.
General stroke signs (may be present)
- Sudden weakness or paralysis, usually affecting the face, arm, or leg on one side.
- Sudden severe headache, especially if it follows a “thunderclap” pattern.
- Altered level of consciousness or sudden confusion.
Because many of these symptoms overlap with vestibular disorders, inner‑ear infections, or migraine, a high index of suspicion is essential, especially in patients with vascular risk factors.
Causes and Risk Factors
Underlying mechanisms
- Thromboembolic occlusion – a clot formed in the heart (e.g., atrial fibrillation, valvular disease) or in proximal arteries travels to the posterior circulation.
- Atherosclerotic plaque rupture – buildup of cholesterol‑rich plaques in the vertebral or basilar arteries can narrow the lumen or break apart, causing an embolus.
- Small‑vessel disease (lacunar infarcts) – chronic hypertension damages the tiny penetrating arteries of the brainstem.
- Dissections – a tear in the vertebral artery wall (often after neck trauma or sudden neck movement) can create a false lumen that blocks flow.
- Hypercoagulable states – inherited (e.g., Factor V Leiden) or acquired (e.g., antiphospholipid syndrome) clotting disorders increase the risk of clot formation.
Key risk factors
- Age >55 years
- Hypertension (most powerful modifiable risk factor) [3]
- Atrial fibrillation or other cardiac arrhythmias
- Diabetes mellitus
- Current smoking or heavy alcohol use
- Hyperlipidemia
- Obesity (BMI ≥ 30 kg/m²)
- Family history of stroke or premature cardiovascular disease
- Prior TIA or stroke (especially in the posterior circulation)
- Recent cervical manipulation or neck trauma (risk for vertebral artery dissection)
Diagnosis
Initial clinical assessment
Emergency physicians use the NIH Stroke Scale (NIHSS) to gauge severity, but the scale is weighted toward anterior‑circulation signs and may underestimate posterior deficits. A focused neuro‑ophthalmic and vestibular exam is therefore crucial.
Imaging studies
- Non‑contrast CT head – performed first to rule out hemorrhage. Early ischemic changes in the posterior fossa may be subtle.
- CT angiography (CTA) or MR angiography (MRA) – visualizes occlusion, stenosis, or dissection of vertebral, basilar, or posterior cerebral arteries.
- Diffusion‑weighted MRI (DW‑MRI) – gold standard for detecting acute infarction within minutes of onset; highly sensitive for posterior fossa lesions.
- CT perfusion (CTP) – helps identify salvageable penumbra when considering thrombolysis or thrombectomy.
- Carotid and vertebral duplex ultrasonography – evaluates for atherosclerotic plaque and flow dynamics.
Cardiac work‑up
Because cardio‑embolic sources are common, patients typically undergo:
- 12‑lead ECG (look for atrial fibrillation, recent MI)
- Telemetry or Holter monitoring (detect intermittent arrhythmias)
- Echocardiography (transthoracic or transesophageal) – assesses for atrial thrombus, patent foramen ovale, or valvular disease.
Laboratory tests
- Complete blood count, electrolytes, renal and liver panels
- Coagulation profile (PT/INR, aPTT) – important before administering thrombolytics.
- Lipid profile, HbA1c (baseline cardiovascular risk assessment)
- Thrombophilia panel if young patient or unexplained stroke.
Treatment Options
Acute management (first 24 hours)
- Intravenous thrombolysis (tPA) – alteplase given within 4.5 hours of symptom onset if no contraindications. Posterior strokes respond similarly to anterior strokes when treated promptly [4].
- Endovascular thrombectomy – recommended for large‑vessel basilar artery occlusion within 6–24 hours if favorable imaging (CTP or MR perfusion) shows viable tissue. Recent trials (e.g., BASILAR) show up to 30 % absolute reduction in mortality.
- Blood pressure management – aim for <120‑185 mmHg systolic before tPA; after reperfusion, maintain SBP < 180 mmHg to reduce hemorrhagic transformation.
- Antiplatelet therapy – if thrombolysis is not given, start aspirin 325 mg loading dose, then 81–325 mg daily.
- Anticoagulation – indicated for atrial fibrillation or cardio‑embolic sources after 24 hours (unless contraindicated). Options include warfarin (INR 2‑3) or direct oral anticoagulants (DOACs) such as apixaban.
Sub‑acute and secondary prevention
- Statin therapy – high‑intensity statin (e.g., atorvastatin 40‑80 mg) reduces recurrent stroke risk by ~20 % [5].
- Blood glucose control – target HbA1c < 7 % for diabetics.
- Smoking cessation – counseling, nicotine replacement, or pharmacotherapy (varenicline, bupropion).
- Dietary modifications – Mediterranean‑style diet rich in fruits, vegetables, whole grains, fish, and olive oil.
- Regular aerobic exercise – at least 150 minutes of moderate‑intensity activity per week.
Rehabilitation
Early, multidisciplinary rehab improves functional outcomes:
- Physical therapy – balance, gait training, and strength exercises.
- Occupational therapy – fine‑motor skills, ADL (activities of daily living) adaptations.
- Speech‑language pathology – for dysphagia or dysarthria.
- Neuro‑psychology – addresses cognitive or emotional sequelae.
Living with Q‑stroke (posterior circulation infarct)
Daily management tips
- Medication adherence – use pill organizers or smartphone reminders; never stop antiplatelet/anticoagulant without doctor approval.
- Blood pressure monitoring – home cuff readings 2‑3 times per week; keep a log for your provider.
- Fall prevention – install grab bars, use non‑slip mats, wear supportive shoes, and keep pathways clear.
- Vision checks – regular ophthalmology visits for visual field defects; adjust lighting and use contrast‑enhancing tools.
- Swallowing safety – follow any diet modifications (e.g., pureed foods) prescribed by a speech therapist; sit upright for at least 30 minutes after meals.
- Stress management – mindfulness, breathing exercises, or counseling can help reduce blood pressure spikes.
- Support networks – join stroke survivor groups, online forums, or community rehab programs for peer encouragement.
When to contact your doctor
- New or worsening weakness, speech changes, or vision loss.
- Persistent dizziness or vertigo despite therapy.
- Signs of bleeding (e.g., bruising, dark stools) while on antithrombotic medication.
- Uncontrolled hypertension (>180/100 mmHg) or any side effect from medication.
Prevention
Primary prevention (before first stroke)
- Control hypertension – target <130/80 mmHg (per 2023 ACC/AHA guidelines) [6].
- Screen for atrial fibrillation – annual ECG for people >65 years or with risk factors.
- Maintain optimal cholesterol – LDL‑C < 70 mg/dL in high‑risk patients.
- Adopt a heart‑healthy diet and regular exercise.
- Avoid excessive alcohol (≤ 2 drinks/day for men, ≤ 1 for women).
- Vaccinations – influenza and COVID‑19 vaccines reduce cardiovascular events.
Secondary prevention (after a Q‑stroke)
- Strict adherence to antithrombotic therapy.
- Regular follow‑up imaging (CTA/MRA) every 1‑2 years to monitor vessel disease.
- Manage sleep apnea – CPAP therapy has been shown to cut recurrent stroke risk.
- Weight management – aim for 5‑10 % weight loss if BMI ≥ 30.
Complications
- Brainstem respiratory failure – can require mechanical ventilation.
- Persistent dysphagia – increases risk of aspiration pneumonia.
- Ataxia and chronic gait instability – leading to falls and fractures.
- Visual field loss – impacts driving and independence.
- Post‑stroke depression or anxiety – seen in up to 30 % of survivors.
- Recurrent stroke – highest risk within the first 90 days without optimal secondary prevention.
When to Seek Emergency Care
- Sudden vertigo or loss of balance accompanied by weakness, numbness, or trouble speaking.
- New double vision, drooping eyelid, or abnormal eye movements.
- Sudden severe headache, especially with a “worst ever” quality.
- Sudden loss of vision in one or both eyes.
- Difficulty swallowing, choking, or a sudden change in consciousness.
- Any rapid change in neurological status, even if symptoms seem mild.
Time is brain – treatment is most effective when started within the first few hours.
References
- Mayo Clinic. “Ischemic stroke.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/ischemic-stroke
- American Heart Association. “Stroke Statistics.” 2022. https://www.heart.org/en/health-topics/stroke/statistics
- CDC. “High Blood Pressure and Stroke.” 2023. https://www.cdc.gov/stroke/hbp.htm
- Jauch EC, et al. “Guidelines for the Early Management of Patients With Acute Ischemic Stroke.” *Stroke*. 2021;52:e364‑e467.
- NIH Stroke Scale &c. “Statins for Secondary Stroke Prevention.” 2022. https://www.nhlbi.nih.gov/health-topics/statins
- ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. 2023.